Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
H.I.G. Capital is a leading global alternative asset manager with $70 billion in assets under management and over three decades of experience investing across private equity, growth equity, direct lending, special situations credit, real estate, infrastructure, and healthcare/life sciences sectors through specialized affiliates such as H.I.G. BioHealth Partners. The firm's healthcare investments span therapeutics, medical devices, diagnostics, pharmaceutical services/digital health—backing both early-stage innovators and established commercial businesses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HIG Equity.